WEBULL
News
EW
84.83
-1.19%
-1.02
Edwards Lifesciences Is Maintained at Buy by Stifel
Dow Jones · 20h ago
Stifel Maintains Buy on Edwards Lifesciences, Raises Price Target to $105
Benzinga · 20h ago
Edwards Lifesciences (EW) Gets a Buy from Stifel Nicolaus
TipRanks · 22h ago
Becton Dickinson price target raised to $215 from $210 at Stifel
TipRanks · 22h ago
Edwards Lifesciences price target raised to $105 from $100 at Stifel
TipRanks · 22h ago
Edwards Lifesciences price target raised to $94 from $92 at Evercore ISI
TipRanks · 2d ago
Bank of America Securities Keeps Their Buy Rating on Edwards Lifesciences (EW)
TipRanks · 2d ago
Weekly Report: what happened at EW last week (1229-0102)?
Weekly Report · 3d ago
Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends
Simply Wall St · 3d ago
BTIG Keeps Their Buy Rating on Edwards Lifesciences (EW)
TipRanks · 4d ago
BTIG’s 2026 top picks report spotlights 21 large-cap stocks to watch
Seeking Alpha · 5d ago
The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price
Seeking Alpha · 12/29/2025 22:28
Weekly Report: what happened at EW last week (1222-1226)?
Weekly Report · 12/29/2025 09:47
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM)
TipRanks · 12/29/2025 09:01
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
NASDAQ · 12/26/2025 17:20
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
NASDAQ · 12/24/2025 13:40
The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences
NASDAQ · 12/23/2025 15:21
Edwards Lifesciences wins FDA nod for SAPIEN M3 TMVR system
Seeking Alpha · 12/23/2025 14:51
Edwards Lifesciences receives FDA approval for SAPIEN M3 mitral valve system
TipRanks · 12/23/2025 14:15
Edwards Lifesciences Says FDA Approves SAPIEN M3 Mitral Valve Replacement System For Treatment Of Mitral Regurgitation
Benzinga · 12/23/2025 14:03
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.